Literature DB >> 23964036

Coinfection of pulmonary mucormycosis and aspergillosis presenting as bilateral vocal cord palsy.

Arun H Mahadevaiah1, Natarajan Rajagopalan, Mahantesh Patil, Shivaprasad C.   

Abstract

Invasive pulmonary coinfection with Mucor and Aspergillus is rare. Bilateral vocal cord paralysis resulting from coinfection with these two fungi to our knowledge has not been reported in the literature. We report a young woman with diabetes who presented with symptoms of community acquired pneumonia in association with hoarseness of voice. Investigations revealed air space consolidation of the right upper lobe, evidence of mediastinal involvement extending into the paratracheal space and entrapment of right upper lobe pulmonary artery. Bronchoscopy revealed bilateral vocal cord paralysis and sloughing of mucosa of the right upper lobe bronchus and the bronchus intermedius. Microbiological and pathological results confirmed Mucor and Aspergillus. Extensive vascular and mediastinal involvement precludes surgical debridement. Despite aggressive medical management the patient deteriorated and died of respiratory failure. Strong suspicion of invasive fungal infections in immune compromised patients presenting with unresolving pneumonia and hoarseness of voice, early aggressive treatment is crucial for the patient survival.

Entities:  

Mesh:

Year:  2013        PMID: 23964036      PMCID: PMC3761694          DOI: 10.1136/bcr-2013-009615

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  18 in total

1.  Spontaneously resolving pulmonary mucormycosis.

Authors:  R Mendoza-Ayala; R Tapia; M Salathe
Journal:  Clin Infect Dis       Date:  1999-11       Impact factor: 9.079

2.  [Tracheal mucormycosis].

Authors:  Jesús Gabriel Sales-Badía; Vicente Zaragoza Hervás; José Marcelo Galbis-Caravajal
Journal:  Arch Bronconeumol       Date:  2009-04-29       Impact factor: 4.872

3.  Pulmonary mucormycosis: another cure.

Authors:  T W Hauch
Journal:  Chest       Date:  1977-07       Impact factor: 9.410

4.  Clinical spectrum of pulmonary mucormycosis.

Authors:  T D Bigby; M L Serota; L M Tierney; M A Matthay
Journal:  Chest       Date:  1986-03       Impact factor: 9.410

Review 5.  Pulmonary mucormycosis: the last 30 years.

Authors:  F Y Lee; S B Mossad; K A Adal
Journal:  Arch Intern Med       Date:  1999-06-28

6.  Predictors of pulmonary zygomycosis versus invasive pulmonary aspergillosis in patients with cancer.

Authors:  Georgios Chamilos; Edith M Marom; Russell E Lewis; Michail S Lionakis; Dimitrios P Kontoyiannis
Journal:  Clin Infect Dis       Date:  2005-05-24       Impact factor: 9.079

7.  Pituitary apoplexy due to mucormycosis infection in a patient with an ACTH producing pulmonary tumor.

Authors:  Citlaltépetl Salinas-Lara; Daniel Rembao-Bojórquez; Erick de la Cruz; Carlos Márquez; Lesly Portocarrero; Martha Lilia Tena-Suck
Journal:  J Clin Neurosci       Date:  2007-04-25       Impact factor: 1.961

8.  Rhinocerebral mucormycosis in a patient with cirrhosis and chronic renal failure.

Authors:  Stavroula Georgopoulou; Ekaterini Kounougeri; Chrisostomos Katsenos; Michael Rizos; Argyris Michalopoulos
Journal:  Hepatogastroenterology       Date:  2003 May-Jun

9.  Zygomycosis in Immunocompromised non-Haematological Patients.

Authors:  George Petrikkos; Miranda Drogari-Apiranthitou
Journal:  Mediterr J Hematol Infect Dis       Date:  2011-03-15       Impact factor: 2.576

10.  Pulmonary mucormycosis: an emerging infection.

Authors:  Mohammed Muqeetadnan; Ambreen Rahman; Syed Amer; Salman Nusrat; Syed Hassan; Syed Hashmi
Journal:  Case Rep Pulmonol       Date:  2012-12-12
View more
  8 in total

Review 1.  Combined Orofacial Aspergillosis and Mucormycosis: Fatal Complication of a Recurrent Paediatric Glioma-Case Report and Review of Literature.

Authors:  Maddalena Chermetz; Margherita Gobbo; Katia Rupel; Giulia Ottaviani; Giancarlo Tirelli; Rossana Bussani; Roberto Luzzati; Roberto Di Lenarda; Matteo Biasotto
Journal:  Mycopathologia       Date:  2016-06-27       Impact factor: 2.574

2.  Coinfection with Lichtheimia corymbifera and Aspergillus flavus in an Immune-Competent Patient Mimicking as Pulmonary-Renal Syndrome.

Authors:  Ali Bin Sarwar Zubairi; Farah Idrees; Kauser Jabeen; Saima Kamal; Afia Zafar
Journal:  Mycopathologia       Date:  2017-02-14       Impact factor: 2.574

3.  Aspergillus and mucormycosis presenting with normal chest X-ray in an immunocompromised host.

Authors:  Vipin Gupta; Natarajan Rajagopalan; Mahantesh Patil; C Shivaprasad
Journal:  BMJ Case Rep       Date:  2014-04-09

4.  A long-term survivor of disseminated Aspergillus and mucorales infection: an instructive case.

Authors:  Setareh Davoudi; Paolo Anderlini; Gregory N Fuller; Dimitrios P Kontoyiannis
Journal:  Mycopathologia       Date:  2014-08-03       Impact factor: 2.574

5.  Characteristics of pulmonary mucormycosis and predictive risk factors for the outcome.

Authors:  Jun Feng; Xuefeng Sun
Journal:  Infection       Date:  2018-05-10       Impact factor: 3.553

6.  Clinical features of pulmonary mucormycosis in patients with different immune status.

Authors:  Min Peng; Hua Meng; Yinghao Sun; Yu Xiao; Hong Zhang; Ke Lv; Baiqiang Cai
Journal:  J Thorac Dis       Date:  2019-12       Impact factor: 2.895

Review 7.  COVID-19-associated mixed mold infection: A case report of aspergillosis and mucormycosis and a literature review.

Authors:  Yasmine Benhadid-Brahmi; Samia Hamane; Benjamin Soyer; Alexandre Mebazaa; Alexandre Alanio; Benjamin Chousterman; Stéphane Bretagne; Sarah Dellière
Journal:  J Mycol Med       Date:  2021-11-26       Impact factor: 2.391

8.  Successful Management of Mixed Mycosis in HIV-Negative Patients With Different Immune Status: A Case Series Report.

Authors:  Yangqing Zhan; Chun Lu; Shaoqiang Li; Jin Zhao; Zhengtu Li; Yingying Gu; Feng Ye
Journal:  Front Cell Infect Microbiol       Date:  2022-03-04       Impact factor: 5.293

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.